Jasmine Register

Jasmine Register supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing critical procurement activities that enable public health response, laboratory diagnostics, and biomedical research. She oversees the acquisition of specialized analytical instruments, in-vitro diagnostic products, and biotechnology solutions essential for infectious disease surveillance and laboratory capacity building. Her work directly advances CDC’s mission by ensuring timely access to high-performance scientific equipment and clinical testing infrastructure, often under time-sensitive operational demands. She handles complex, technically demanding contracts requiring deep domain knowledge in life sciences and public health infrastructure. Jasmine maintains consistent partnerships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid. These relationships reflect a focus on high-reliability vendors with proven capabilities in diagnostic manufacturing, laboratory automation, and data-driven public health systems. Her contracting approach emphasizes performance-based requirements, technical compliance, and long-term operational sustainability, often involving multi-year delivery orders and service-level agreements tied to mission-critical outcomes. Her procurement strategy prioritizes open competition, with 93.3% of awards issued without set-aside designations, reflecting a preference for broad market engagement to secure the highest technical quality. While small business participation is limited at 6.7%, it is strategically directed toward total small business set-asides under FAR 19.5, indicating a deliberate but selective approach to socioeconomic contracting aligned with mission needs rather than quota-driven goals. Her primary procurement focus lies in NAICS 334516 (analytical laboratory instrument manufacturing) and 325413 (in-vitro diagnostic substance manufacturing), underscoring deep expertise in securing advanced diagnostic platforms, molecular testing systems, and clinical laboratory reagents. She routinely procures FDA-regulated medical devices and biologics, requiring rigorous adherence to regulatory and quality standards, and demonstrates specialized knowledge in the technical specifications governing diagnostic accuracy, throughput, and biosafety compliance.